Baidu
map

这样竟然能发Lancet?!样本量92例,6周就出结果……

2019-12-09 郑卫军 医学论文与统计分析

快来学习一下!

Lancet 杂志显然是我们大多数人不可期盼的顶级医学杂志,开玩笑说,一旦发表一篇,百万奖金妥妥的。

就在上周,荷兰科学家做了一个其实不难的临床试验:针对手关节炎患者,两家医院,92例患者,6周时间,证明了泼尼松龙有助于短期缓解疼痛。



泼尼松龙抗炎药,不是有助于治疗关节炎吗,这样不算什么新闻呀!然而就是这么简单的一个假设,居然没有人正儿八经研究过,还发表在2019年11月30号的Lancet 主刊。

我们不妨拿个板凳坐一坐,看看这篇论文怎么写的。

1. 为什么研究?

手骨关节炎是一种常见的关节疾病,其特征为关节僵硬和疼痛。目前治疗仅限于局部和口服非甾体抗炎药(NSAID)以缓解疼痛。然而,研究表明,滑膜炎症通常存在于手关节炎中,是疼痛和放射学疾病进展的主要决定因素。但是没有分析过短期低剂量泼尼松龙治疗手关节炎疼痛的疗效和安全性。



2. 研究方法

Study design:这是一项随机、双盲、安慰剂对照试验。共纳入标准92例患者,随机分到泼尼松龙组(10mg,n=46)和安慰剂组(n=46),持续6周。还有一个为期2周逐渐减量的计划,6周不服用研究药物。在第2、4、6、8和14周评估结果。

Patients:纳入患者均符合美国风湿病学会的标准,并有滑膜炎症的迹象。骨关节炎结节≥4个指间关节(IPJ)、软肿胀或红斑≥1个IPJ、超声功率多普勒信号(PDS)阳性或滑膜炎分级≥2个IPJ的患者符合条件。

Intervention & control:泼尼松龙组,10mg每天泼尼松龙;对照组,安慰剂

Outcome:主要终点是第6周的手指VAS疼痛评分;次要临床终点包括OMERACT-OARSI标准、澳大利亚和加拿大手部骨性关节炎指数(AUSCAN)疼痛评分、手OA功能指数(FIHOA)、患者总体评价VAS评分、生活质量评价表SF-36和握力。成像终点包括超声滑膜炎和PDS。

统计学方法:因为是重复测量资料,采用广义估计方程(Generalised Estimating Equations)进行分析。没有其它方法了。

郑老师:诸位看官,你们看他们的方法简单不?样本量少、手关节炎患者伦理学问题不大,时间不长,方法也没有那么复杂,结局指标也就是患者报告结局。容易!真实太容易了!

3. 研究结果

主要结局指标

VAS手指疼痛的平均值从基线到第6周的变化,泼尼松龙组中为-21.5(21.7),安慰剂组中为-5.2(24.3),组间平均差异为-16.5(95%CI:-26.1 - 6.9)。


随访期间疼痛评分变化和第六周OR值

次要结局指标

次要终点结果显示,33例(72%)的泼尼松龙治疗组患者和15例(33%)的安慰剂组患者符合OARSI反应者标准(OR = 5.3; P = .001)。与主要终点相似,泼尼松龙在他次要临床终点方面优于安慰剂。

与安慰剂组相比,泼尼松龙在第6周时超声滑膜炎明显改善,而安慰剂组无统计学差异。逐渐减少后,组间差异消失。两组的不良事件多为轻度且未报告新的安全风险。



4. 闲来郑语

又是拼爹作品?虽说这个研究干预措施确实没有做过,idea不错,但是其它根本没有困难好吧。。。有。。。作者说俺们荷兰,病人少,手关节炎病例很难找,好不容易找到92例。然后Lancet专门写了一篇评论说作者确实做得很辛苦。这都是神马和神马玩意?

我觉得中国的科学家可以在此基础上大干一场,92例?中国做好920例也没有问题!

最后我想说的,很多临床试验,其实如果想法好,设计规范,真的不怕top杂志不要。关键真实、可信、正确、规范!别乱来,都有机会!


来源:医学论文与统计分析

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1830360, encodeId=aed01830360ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 04:20:00 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669414, encodeId=51be166941417, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Fri Jan 10 09:20:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283479, encodeId=f04312834e98e, content=<a href='/topic/show?id=302e6204212' target=_blank style='color:#2F92EE;'>#样本量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62042, encryptionId=302e6204212, topicName=样本量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Wed Dec 11 00:20:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376771, encodeId=b0393e677109, content=国内马上模仿一篇, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/1a6da650139042b5a600d835b1c7dd57/5a285e3bdcd14aa78af953ff21d37459.jpg, createdBy=53cd2492871, createdName=陨泣, createdTime=Tue Dec 10 10:38:04 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376758, encodeId=ac0c3e67581f, content=已学习已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Tue Dec 10 05:14:58 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376737, encodeId=5f493e6737b6, content=其一研究很难,其二专注,其三是减量有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Dec 09 14:19:56 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376728, encodeId=d4703e6728d4, content=小编在干嘛?吃两粒花生米呗, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce4f5243184, createdName=147c5d8bm52暂无昵称, createdTime=Mon Dec 09 11:09:21 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
    2020-05-24 howi
  2. [GetPortalCommentsPageByObjectIdResponse(id=1830360, encodeId=aed01830360ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 04:20:00 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669414, encodeId=51be166941417, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Fri Jan 10 09:20:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283479, encodeId=f04312834e98e, content=<a href='/topic/show?id=302e6204212' target=_blank style='color:#2F92EE;'>#样本量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62042, encryptionId=302e6204212, topicName=样本量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Wed Dec 11 00:20:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376771, encodeId=b0393e677109, content=国内马上模仿一篇, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/1a6da650139042b5a600d835b1c7dd57/5a285e3bdcd14aa78af953ff21d37459.jpg, createdBy=53cd2492871, createdName=陨泣, createdTime=Tue Dec 10 10:38:04 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376758, encodeId=ac0c3e67581f, content=已学习已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Tue Dec 10 05:14:58 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376737, encodeId=5f493e6737b6, content=其一研究很难,其二专注,其三是减量有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Dec 09 14:19:56 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376728, encodeId=d4703e6728d4, content=小编在干嘛?吃两粒花生米呗, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce4f5243184, createdName=147c5d8bm52暂无昵称, createdTime=Mon Dec 09 11:09:21 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
    2020-01-10 zhzhxiang
  3. [GetPortalCommentsPageByObjectIdResponse(id=1830360, encodeId=aed01830360ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 04:20:00 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669414, encodeId=51be166941417, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Fri Jan 10 09:20:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283479, encodeId=f04312834e98e, content=<a href='/topic/show?id=302e6204212' target=_blank style='color:#2F92EE;'>#样本量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62042, encryptionId=302e6204212, topicName=样本量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Wed Dec 11 00:20:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376771, encodeId=b0393e677109, content=国内马上模仿一篇, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/1a6da650139042b5a600d835b1c7dd57/5a285e3bdcd14aa78af953ff21d37459.jpg, createdBy=53cd2492871, createdName=陨泣, createdTime=Tue Dec 10 10:38:04 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376758, encodeId=ac0c3e67581f, content=已学习已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Tue Dec 10 05:14:58 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376737, encodeId=5f493e6737b6, content=其一研究很难,其二专注,其三是减量有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Dec 09 14:19:56 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376728, encodeId=d4703e6728d4, content=小编在干嘛?吃两粒花生米呗, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce4f5243184, createdName=147c5d8bm52暂无昵称, createdTime=Mon Dec 09 11:09:21 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1830360, encodeId=aed01830360ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 04:20:00 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669414, encodeId=51be166941417, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Fri Jan 10 09:20:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283479, encodeId=f04312834e98e, content=<a href='/topic/show?id=302e6204212' target=_blank style='color:#2F92EE;'>#样本量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62042, encryptionId=302e6204212, topicName=样本量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Wed Dec 11 00:20:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376771, encodeId=b0393e677109, content=国内马上模仿一篇, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/1a6da650139042b5a600d835b1c7dd57/5a285e3bdcd14aa78af953ff21d37459.jpg, createdBy=53cd2492871, createdName=陨泣, createdTime=Tue Dec 10 10:38:04 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376758, encodeId=ac0c3e67581f, content=已学习已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Tue Dec 10 05:14:58 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376737, encodeId=5f493e6737b6, content=其一研究很难,其二专注,其三是减量有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Dec 09 14:19:56 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376728, encodeId=d4703e6728d4, content=小编在干嘛?吃两粒花生米呗, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce4f5243184, createdName=147c5d8bm52暂无昵称, createdTime=Mon Dec 09 11:09:21 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
    2019-12-10 陨泣

    国内马上模仿一篇

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1830360, encodeId=aed01830360ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 04:20:00 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669414, encodeId=51be166941417, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Fri Jan 10 09:20:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283479, encodeId=f04312834e98e, content=<a href='/topic/show?id=302e6204212' target=_blank style='color:#2F92EE;'>#样本量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62042, encryptionId=302e6204212, topicName=样本量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Wed Dec 11 00:20:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376771, encodeId=b0393e677109, content=国内马上模仿一篇, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/1a6da650139042b5a600d835b1c7dd57/5a285e3bdcd14aa78af953ff21d37459.jpg, createdBy=53cd2492871, createdName=陨泣, createdTime=Tue Dec 10 10:38:04 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376758, encodeId=ac0c3e67581f, content=已学习已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Tue Dec 10 05:14:58 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376737, encodeId=5f493e6737b6, content=其一研究很难,其二专注,其三是减量有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Dec 09 14:19:56 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376728, encodeId=d4703e6728d4, content=小编在干嘛?吃两粒花生米呗, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce4f5243184, createdName=147c5d8bm52暂无昵称, createdTime=Mon Dec 09 11:09:21 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
    2019-12-10 15938038573红旗飘飘

    已学习已分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1830360, encodeId=aed01830360ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 04:20:00 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669414, encodeId=51be166941417, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Fri Jan 10 09:20:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283479, encodeId=f04312834e98e, content=<a href='/topic/show?id=302e6204212' target=_blank style='color:#2F92EE;'>#样本量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62042, encryptionId=302e6204212, topicName=样本量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Wed Dec 11 00:20:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376771, encodeId=b0393e677109, content=国内马上模仿一篇, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/1a6da650139042b5a600d835b1c7dd57/5a285e3bdcd14aa78af953ff21d37459.jpg, createdBy=53cd2492871, createdName=陨泣, createdTime=Tue Dec 10 10:38:04 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376758, encodeId=ac0c3e67581f, content=已学习已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Tue Dec 10 05:14:58 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376737, encodeId=5f493e6737b6, content=其一研究很难,其二专注,其三是减量有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Dec 09 14:19:56 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376728, encodeId=d4703e6728d4, content=小编在干嘛?吃两粒花生米呗, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce4f5243184, createdName=147c5d8bm52暂无昵称, createdTime=Mon Dec 09 11:09:21 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
    2019-12-09 lovetcm

    其一研究很难,其二专注,其三是减量有价值

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1830360, encodeId=aed01830360ba, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sun May 24 04:20:00 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1669414, encodeId=51be166941417, content=<a href='/topic/show?id=9d7b620395d' target=_blank style='color:#2F92EE;'>#样本#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62039, encryptionId=9d7b620395d, topicName=样本)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f33226554040, createdName=zhzhxiang, createdTime=Fri Jan 10 09:20:00 CST 2020, time=2020-01-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1283479, encodeId=f04312834e98e, content=<a href='/topic/show?id=302e6204212' target=_blank style='color:#2F92EE;'>#样本量#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62042, encryptionId=302e6204212, topicName=样本量)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b05b180, createdName=grace5700, createdTime=Wed Dec 11 00:20:00 CST 2019, time=2019-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376771, encodeId=b0393e677109, content=国内马上模仿一篇, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200614/1a6da650139042b5a600d835b1c7dd57/5a285e3bdcd14aa78af953ff21d37459.jpg, createdBy=53cd2492871, createdName=陨泣, createdTime=Tue Dec 10 10:38:04 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376758, encodeId=ac0c3e67581f, content=已学习已分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231215/ac08b4d4cecf4bd3b9af86e00dcbca38/f6b6a60efd854ff191eb5c611ec7dd12.jpg, createdBy=8afb2071832, createdName=15938038573红旗飘飘, createdTime=Tue Dec 10 05:14:58 CST 2019, time=2019-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376737, encodeId=5f493e6737b6, content=其一研究很难,其二专注,其三是减量有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=lovetcm, createdTime=Mon Dec 09 14:19:56 CST 2019, time=2019-12-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=376728, encodeId=d4703e6728d4, content=小编在干嘛?吃两粒花生米呗, beContent=null, objectType=article, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ce4f5243184, createdName=147c5d8bm52暂无昵称, createdTime=Mon Dec 09 11:09:21 CST 2019, time=2019-12-09, status=1, ipAttribution=)]
    2019-12-09 147c5d8bm52暂无昵称

    小编在干嘛?吃两粒花生米呗

    0

相关资讯

盘点:2019年11月16日Lancet研究精选

2019年11月16日Lancet研究精选

盘点:2019年12月7日Lancet研究精选

2019年12月7日Lancet研究精选

盘点:2019年11月23日Lancet研究精选

2019年11月23日Lancet研究精选

The Lancet:接受依非韦伦治疗的艾滋病感染孕妇所生婴儿的小头畸形风险增加

美国国立卫生研究院(National Institutes of Health)资助的一项研究显示,接受含有依非韦伦(efavirenz)药物治疗的艾滋病毒感染孕妇所生婴儿的头畸形或小头畸形患儿的几率是接受其他抗逆转录病毒药物治疗的2到2.5倍。与正常头大小的儿童相比,小头畸形的儿童发育迟缓的风险也更高。这项研究是由哈佛公共卫生学院的Paige L. Williams博士及其同事完成的,发表在《柳

盘点:2019年11月9日Lancet研究精选

2019年11月9日Lancet研究精选

盘点:2019年11月30日Lancet研究精选

2019年11月30日Lancet研究精选

Baidu
map
Baidu
map
Baidu
map